首页|复方苦参注射液对原发性肝癌及肝转移癌TACE术后的中医证候、肝功能的影响研究

复方苦参注射液对原发性肝癌及肝转移癌TACE术后的中医证候、肝功能的影响研究

扫码查看
目的:探讨苦参注射液对原发性肝癌及肝转移癌肝动脉化疗栓塞术(TACE)术后的中医证候、肝功能的影响.方法:选择2019年1月至2022年12月在本院治疗的82例原发性肝癌及肝转移癌TACE后患者作为研究对象.将82例患者按照随机数表法分为对照组和观察组各41例.对照组仅给予对症支持治疗,观察组在给予对症支持治疗的基础之上同时给予复方苦参注射液20mL加入生理盐水250ml进行静脉滴注治疗,每日一次,以一周为一个疗程.比较两组患者治疗前后的中医证候中肝区疼痛、腹胀、乏力、纳差积分、肝功能指标中的谷丙转氨酶(ALT)、谷草转氨酶(AST)水平白蛋白(ALb)水平,同时比较两组患者不良反应(恶心呕吐、皮疹、头晕、腹痛)发生率.结果:术前1d,两组患者的ALT、AST水平以及ALb水平均高于治疗前(P<0.05);观察组ALT、AST水平明显低于对照组,ALb水平高于对照组(P<0.05).两组术后2周的中医证候积分都低于术前1d,且观察组低于对照组(P<0.05);观察组患者对于肝区疼痛、乏力、纳差、腹胀的频分低于对照组(P<0.05);观察组不良反应发生率为4.87%,明显低于对照组(36.52%,P<0.05).结论:复方苦参注射液对原发性肝癌及肝转移癌TACE术后可以有效的增强患者肝功能,减少术后不良反应发生率,提高患者的生活质量.值得在临床上推广运用.
Objective:To explore the effect of Sophora flavescens injection on traditional Chinese medicine syndrome and liver function after hepatic artery chemoembolization(TACE)for primary liver cancer and liver metastasis.Method:82 patients with primary liver cancer and liver metastasis treated in our hospital from January 2019 to December 2022 after TACE were selected as the study subjects.82 patients were divided into a control group and an observation group using a random number table method,with 41 patients in each group.The control group was only given symptomatic support treatment,while the observation group was given 20mL of compound Sophora flavescens injection and 250ml of physiological saline for intravenous drip treatment on the basis of symptomatic support treatment,once a day for a week as a course of treatment.The traditional Chinese medicine symptoms of liver pain,abdominal distension,fatigue,anorexia score,liver function indicators such as alanine aminotransferase(ALT)and aspartate aminotransferase(AST)levels and albumin(ALb)levels in two groups of patients before and after treatment were compared,and the incidence of adverse reactions(nausea,vomiting,rash,dizziness,and abdominal pain)between the two groups of patients were compared.Result:On the first day before surgery,the levels of ALT,AST,and ALb in both groups of patients were higher than before treatment(P<0.05);the levels of ALT and AST in the observation group were significantly lower than those in the control group,while the levels of ALb were higher than those in the control group(P<0.05).The TCM syndrome scores of both groups were lower at 2 weeks after surgery than at 1 day before surgery,and the observation group was lower than the control group(P<0.05);the frequency of liver pain,fatigue,poor appetite,and abdominal distension in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05);the incidence of adverse reactions in the observation group was 4.87%,which was significantly lower than 36.52%in the control group(P<0.05).Conclusion:Compound Sophora flavescens injection can effectively enhance liver function,reduce the incidence of postoperative adverse reactions,and improve the quality of life of patients with primary liver cancer and liver metastasis after TACE surgery,which is worth promoting and applying in clinical practice.

Primary liver cancerLiver metastatic carcinomaHepatic artery chemoembolizationCompound Sophora flavescens injectionTraditional Chinese Medicine SyndromeImmune functionliver function

张玲兰、山铁荣、余林燕

展开 >

江西鄱阳湖医院 江西上饶 333105

原发性肝癌 肝转移癌 肝动脉化疗栓塞术 复方苦参注射液 中医证候 免疫功能 肝功能

2023

黑龙江中医药
黑龙江省中医研究院

黑龙江中医药

影响因子:0.425
ISSN:1000-9906
年,卷(期):2023.52(5)
  • 12